Company Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries.
The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution.
Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents.
Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
| Country | United States |
| Founded | 2003 |
| IPO Date | Aug 3, 2012 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 5,300 |
| CEO | Daniel Scavilla |
Contact Details
Address: 2560 General Armistead Avenue Audubon, Pennsylvania 19403 United States | |
| Phone | 610 930 1800 |
| Website | globusmedical.com |
Stock Details
| Ticker Symbol | GMED |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001237831 |
| CUSIP Number | 379577208 |
| ISIN Number | US3795772082 |
| Employer ID | 04-3744954 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Daniel T. Scavilla | President, Chief Executive Officer and Director |
| David C. Paul | Co-Founder and Executive Chairman |
| Keith W. Pfeil | Chief Financial Officer and Chief Operating Officer |
| Kelly G. Huller Esq. | Executive Vice President, General Counsel and Corporate Secretary |
| Brian J. Kearns | Senior Vice President of Business Development and Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 24, 2025 | SCHEDULE 13G/A | Filing |
| Apr 3, 2025 | 8-K | Current Report |
| Feb 28, 2025 | 144 | Filing |
| Feb 20, 2025 | 10-K | Annual Report |
| Feb 20, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 6, 2025 | 8-K | Current Report |
| Feb 5, 2025 | SCHEDULE 13G/A | Filing |